MAPT and Alzheimer disease: Our approach identifies sex-specific, sex-dimorphic, and sex-neutral gene expression changes across multiple cell types, including major AD-associated cell populations, such as neurons, astrocytes, microglia, and oligodendrocytes, to better understand cell type-specific responses to tau pathology in both sexes.